medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2008, Number 585

<< Back Next >>

Rev Med Cos Cen 2008; 65 (585)

Brucelosis

Lara VHP, Sanabria FS

Language: Spanish
References: 20
Page: 303-306
PDF size: 134.87 Kb.


ABSTRACT

Brucellosis is a highly contagious bacterial zoonosis that affects millions of people worldwide. Brucellosis behaves as a systemic infection with a very heterogeneous clinical spectrum. Human brucellosis affects all age-groups, and physicians are not well versed in recognizing and treating this potentially life-threatening condition.


REFERENCES

  1. Agasthya A, Isloor S, Prabhudas K. Brucellosis in the High Risk Group Individuals. Indian Journal of Medical Microbiology, 2007; 25: 28-31.

  2. Al-Kharfy T. Neonatal Brucellosis and Blood Transfusion: Case Report and Review of the Literature. Annals of Tropical Paediatrics, 2001; 21: 349-352.

  3. Ariza et al. Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioninna Recommendations. Plosmedicine, 2007; 4: e317.doi:10.1371/journal.pmed.0040317.

  4. Bahemuka M, et al. Neurological Syndromes of Brucellosis. Journal of Neurosurgery and Psychiatry, 1988; 51: 1017-1021.

  5. Colmenero J, et al. Osteoarticular Complications of Brucellosis. Annals of the Rheumatic Diseases, 1991; 50: 23-26.

  6. Ertek M et al. Comparison of the Diagnostic Value of the Standard Tube Agglutination Test and the ELISA IgG and IgM in Patients with Brucellosis. Turk J Med Sci, 2006; 36: 159-163.

  7. Ertek M et al. Complications of Brucella Infection Among Adults: An 18-year Retrospective Evaluation. Turk J Med Sci, 2006; 36: 377-381.

  8. Fowler T, Keener J, Buckwalter M. Brucella Osteomyelitis of the Proximal Tibia a Case Report. The Iowa Orthopaedic Journal, 2004; 24: 30-32.

  9. Gamazo et al. Chemical and Biological Factors in the Control of Brucella and Brucellosis. Current Drug Delivery, 2006; 3: 359-365.

  10. González G, et al. Meningitis como Primera y Única Manifestación de Brucelosis. Anales Españoles de Pediatría, 2000; 53: 280-282.

  11. Khan M et al. Brucellosis in Pregnant Women. CID, 2001; 32: 1172-1777.

  12. Lucero N, et al. Diagnosis of Human Brucellosis Caused by Brucella canis. Journal of Medical Microbiology, 2005; 54: 457-461.

  13. Mantur B, Amarnath S, Shinde R. Review of Clinical and Laboratory Features of Human Brucellosis. Indian Journal of Medical Microbiology, 2007; 25: 188-202.

  14. Metin A, et al. Cutaneous Findings Encountered in Brucellosis and Review of the Literature. International Journal of Dermatology, 2001; 40: 434-438.

  15. Ocon P, et al. Phagocytic Cell Function in Active Brucellosis. Infection and Inmunnity, 1994; 62: 910-914.

  16. Pappas G et al. Brucellosis and the Respiratory System. CID, 2003; 37: e95-99.

  17. Sauret J, Vilissova N. Human Brucellosis. JABFP, 2002; 15: 401-405.

  18. Skalsky K et al. Treatment of Human Brucellosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials. BMJ 2008; doi:10.1136/bmj.39497.500903.25.

  19. Tabbara K, Al-Kassimi. Ocular Brucellosis. British Journal of Ophtalmology, 1990; 74: 249-250.

  20. Young EJ. An Overview of Human Brucellosis. Clin Infect Dis, 1995; 21: 283-290.




2020     |     www.medigraphic.com